Literature DB >> 24183855

Improving the quality of mental health care in multiple sclerosis.

S L Minden1, L Ding, P D Cleary, D Frankel, B I Glanz, B C Healy, D J Rintell.   

Abstract

OBJECTIVE: An exploratory study of mental health treatment of people with multiple sclerosis (MS) to identify hypotheses for future testing.
METHODS: We mailed surveys to 8750 MS patients in four geographically distributed MS Centers; 3384 completed the survey. We used a modified version of the Experience of Care and Health Outcome Survey™ to assess mental health problems and experiences with mental health treatment and the Kessler 6 scale to identify serious mental illness.
RESULTS: In the year before the survey, sixty percent of patients reported mental health problems. Less than one half of these individuals received mental health treatment, either from their MS care provider or a mental health professional in the MS Center or the community. Patients generally had good mental health treatment experiences, and felt helped by their treatment, but gave less positive reports about how long it took to be seen, receiving information about treatment options and managing their condition, and phone contact. Care experiences were more positive among those who received care from mental health professionals (compared to medical care providers) and among those receiving mental health treatment in the MS Center (compared to in the community).
CONCLUSIONS: The unmet need for mental health treatment for people with MS is high. Options for MS care providers to help meet this need include hiring mental health professionals to provide on-site treatment; providing mental health treatment themselves; and referring patients to mental health professionals in the community and collaborating in integrated care. This study provided preliminary data for two related hypotheses that warrant further testing: MS patients will receive better mental health care if their mental health treatment is co-located with their MS care and if it is provided by mental health professionals.
© 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CAHPS; Mental health problems; Mental health service utilization; Mental health treatment; Multiple Sclerosis; Patient care experience

Mesh:

Year:  2013        PMID: 24183855     DOI: 10.1016/j.jns.2013.08.021

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

Review 1.  Wellness and the Role of Comorbidities in Multiple Sclerosis.

Authors:  Brandon P Moss; Mary R Rensel; Carrie M Hersh
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

2.  A Framework of Care in Multiple Sclerosis, Part 2: Symptomatic Care and Beyond.

Authors:  Scott D Newsome; Philip J Aliotta; Jacquelyn Bainbridge; Susan E Bennett; Gary Cutter; Kaylan Fenton; Fred Lublin; Dorothy Northrop; David Rintell; Bryan D Walker; Megan Weigel; Kathleen Zackowski; David E Jones
Journal:  Int J MS Care       Date:  2017 Jan-Feb

3.  Reviewing the Unmet Needs of Patients with Multiple Sclerosis.

Authors:  Stanton R Mehr; Marj P Zimmerman
Journal:  Am Health Drug Benefits       Date:  2015-11

4.  Lifestyle factors, demographics and medications associated with depression risk in an international sample of people with multiple sclerosis.

Authors:  Keryn L Taylor; Emily J Hadgkiss; George A Jelinek; Tracey J Weiland; Naresh G Pereira; Claudia H Marck; Dania M van der Meer
Journal:  BMC Psychiatry       Date:  2014-12-03       Impact factor: 3.630

5.  A 10-year population-based study of people with multiple sclerosis in Stockholm, Sweden: use of and satisfaction with care and the value of different factors in predicting use of care.

Authors:  Charlotte Chruzander; Sverker Johansson; Kristina Gottberg; Ulrika Einarsson; Jan Hillert; Lotta Widén Holmqvist; Charlotte Ytterberg
Journal:  BMC Health Serv Res       Date:  2015-10-24       Impact factor: 2.655

6.  Effect of a transactional model education program on coping effectiveness in women with multiple sclerosis.

Authors:  Hormoz Sanaeinasab; Mohsen Saffari; Mahrokh Hashempour; Ali-Akbar Karimi Zarchi; Waleed A Alghamdi; Harold G Koenig
Journal:  Brain Behav       Date:  2017-09-21       Impact factor: 2.708

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.